EXPERIENCE
February 2002-Present
BURKE PHARMACEUTICAL RESEARCH
Clinical Research Coordinator
3633 Central Avenue, Suite I
Hot Springs, AR 71913
(501) 620-4449

JOB DESCRIPTION
Efficiently coordinate and conduct clinical activities, including participant recruitment and screening, data specimen collection and study medication dispensation, according to protocol.
Develop and maintain complete and accurate federal regulatory document files and study patient case histories.

EDUCATION / MEMBERSHIPS
Graduate of Dierks High School
University of Arkansas at Nashville
Fall 1998 – Spring 2000
Honors: President’s List and Dean’s List
(ACRP) Association of Clinical Research Professionals
CPR – Adult, Infant and Pediatric current

LICENSES/CERTIFICATIONS
Arkansas State Board of Nursing, Licensed Practical Nurse, August 1999 to present
Association of Clinical Research Professionals, Certified Clinical Research Coordinator, March 2004

PREVIOUS EXPERIENCE
April 2000 - February 2002
Central Arkansas Cardiovascular Institute
Clinic Nurse
Hot Springs, Arkansas

CLINICAL TRIALS
Phase I – IV Treatment for Moderate to Severe Psoriasis
Phase I – Nasal Spray Treatment for Pediatric Allergic Rhinitis
Phase I/II – Topical Treatment for Onychomycosis
Phase II – Topical Treatment for Plaque Psoriasis
Phase II – Oral Treatment for Moderate to Severe Plaque Psoriasis
Phase II – Topical Treatment for Genital Herpes
Phase II – Oral Treatment for Androgenetic Alopecia
Phase II – Oral Treatment for Acne Vulgaris
Phase II – Oral Treatment for Plaque Psoriasis
Phase II – Topical Treatment for Actinic Keratosis of the Face and Scalp for Adults
Phase III – Topical Treatment for Atopic Dermatitis
Phase III – Topical Treatment for Actinic Keratosis
Phase III – Topical Treatment for Mild to Moderate Pediatric Atopic Dermatitis
Phase III – Topical Treatment for Moderate to Severe Atopic Dermatitis
Phase III – Topical Treatment for Fingernail Onychomycosis
Phase III – Topical Treatment for Tinea Pedis
Phase III – Topical Treatment for Plaque-Type Psoriasis
Phase III – Oral Treatment for Acne Vulgaris
Phase III – Topical Treatment for Actinic Keratosis
Phase III – I.V. Treatment for Subjects with Moderate to Severe Psoriasis
Phase III – I.M. Treatment for Subjects with Moderate to Severe Plaque Psoriasis
Phase III – Topical Treatment for Basal Cell Carcinoma
Phase III – Topical Treatment for Onychomycosis
Phase III – Intralesional Treatment for Plaque Psoriasis
Phase III – Topical Treatment for Superficial Basal Cell Carcinoma
Phase III – Topical Treatment for Plaque Psoriasis in Adult Patients
Phase III – Topical Treatment for Psoriasis
Phase III – Topical Treatment Acne Vulgaris
Phase IIIB – Topical Treatment for Atopic Dermatitis for Children
Phase IIIB – Oral Treatment for Herpes Labialis
Phase IV – Topical Treatment for Identical Twins with Actinic Damage
Phase IV – Oral Treatment for Identical Twins with Male Pattern Hair Loss
Phase IV – I.V. Treatment for Skin Infection
Phase IV – Oral Treatment for Genital Herpes
Phase IV – SC Treatment for Subjects with Psoriatic Arthritis
Phase IV – Treatment for Subjects with Moderate to Severe Psoriasis
A Data Collection Study for Psoriasis and Healthy Volunteers
Validation Study for Alopecia

THE ABOVE CLINICAL TRIALS WERE CONDUCTED BY THE FOLLOWING COMPANIES
3M Pharmaceuticals
Abgenix
Allergan
Altana
Amgen
Astllas
Barrier
Bertek Pharmaceuticals
Biogen
Centocor
Connetics
Dermik
Derm Tech
Dow Pharmaceutical
Fujisawa
Galderma Laboratories
Genomics
Glaxo/SmithKline
Healthpoint
Icon
Macro Chem
Medicis Pharmaceuticals
Novartis
Teva
Therapeutics/Ferndale
Watson Laboratories



INDICATIONS
Acne Vulgaris
Actinic Damage
Actinic Keratosis
Atopic Dermatitis
Basal Cell Carcinoma
Herpes
Male Pattern Hair Loss
Mild to Moderate Psoriasis
Onychomycosis
Pediatric Atopic Dermatitis
Psoriatic Arthritis
Severe Plaque Psoriasis
Skin Infection

MEETINGS / SEMINARS
Clinmetrics Investigator Meeting, July 14-15, 2005 – Chicago, IL
Barrier Investigator Meeting, May 13-14, 2005– Washington, DC
Connetics Investigator Meeting, January 14-15, 2005 – San Francisco, CA
Nursing Law 2004 Seminar, September 3, 2004– Hot Springs, AR Synta Pharmaceutical Investigator Meeting, August 28-29, 2004 – Chicago, IL TKL Investigator Meeting, January 23-24, 2004 – Las Vegas, NY Boeringer Investigator Meeting, November 14-16, 2003 – Dallas, TX
Centocor Investigator Meeting, September 19-21, 2003 – Orlando, FL
Medicis Investigator Meeting, August 22-23, 2003 – Scottsdale, AZ
Amgen Investigator Meeting, June 27-28, 2003 – Santa Monica, CA
Altana Pharmaceutical Investigator Meeting, April 3-7, 2003 – St. Thomas, USVI
Association of Clinical Research Professionals – ACRP Winter Symposium,
February 15-16, 2002 – St. Petersburg, FL